Status:
COMPLETED
Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Pregnancy Related
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to reduce unin...
Detailed Description
Based on previous work, the investigators have generated a toolkit to guide the integration of immediate postpartum LARC services into widespread clinical practice. In the proposed work, this toolkit ...
Eligibility Criteria
Inclusion
- Female (patients)
- Pregnant (patients)
- Receiving obstetrical care at Michigan Medicine (patients)
- L\&D provider at Michigan Medicine (providers)
Exclusion
- non-English speaking
- unable to provide informed consent
Key Trial Info
Start Date :
September 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2020
Estimated Enrollment :
592 Patients enrolled
Trial Details
Trial ID
NCT03774797
Start Date
September 1 2018
End Date
August 16 2020
Last Update
February 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Michigan Medicine
Ann Arbor, Michigan, United States, 48109